Simplifying Global Compliance
U.S.-EU Partnership on GMP Inspections Adds Five Countries
International Pharmaceutical Regulatory Monitor
The FDA has agreed to recognize drug and active pharmaceutical ingredient GMP inspections carried out by authorities in Belgium, Denmark, Finland, Latvia and Estonia, updating the 1998 mutual recognition agreement between the U.S. and the European Union.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor
Buy This Article Now
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing